Entering text into the input field will update the search result below

iCAD, Hologic gain after update on breast cancer screening

May 09, 2023 12:13 PM ETiCAD, Inc. (ICAD), HOLXSMMNY, SEMHF, GEHCBy: Dulan Lokuwithana, SA News Editor2 Comments
Bouquet of cosmos flowers with prescription for mammogram

CatLane/iStock via Getty Images

  • Cancer test makers iCAD (NASDAQ:ICAD) and Hologic (NASDAQ:HOLX) recorded sharp gains on Tuesday after the U.S. Preventive Services Task Force issued draft changes to breast cancer screening guidelines.
  • Per the proposed guidelines, the task force recommends all women undergo mammography screening

Recommended For You

Comments (2)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Pineapple_Paul profile picture
iCAD needs all the good news it can get. Visibility for a small stock is rough.
Carson7 profile picture
NDRA has no ownership in this space. They are targeting fatty liver.

Related Stocks

SymbolLast Price% Chg
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.